Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1464110

Vanderbilt Medical Center - Developmental Therapeutics Review - Q4 2010

Description:

Vanderbilt Medical Center – Developmental Therapeutics Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Vanderbilt Medical Center – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope

- Review of therapeutics under development by Vanderbilt Medical Center.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Vanderbilt Medical Center with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of Vanderbilt Medical Center’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.

Reasons to buy

- Identify new drug targets and therapeutic classes in Vanderbilt Medical Center’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate Vanderbilt Medical Center’s position with total access to a detailed information on its therapeutic products development.
- Assess the growth potential of Vanderbilt Medical Center in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with Vanderbilt Medical Center.
- Avoid Intellectual Property Rights related issues.

Contents:

List of Tables
List of Figures
Vanderbilt Medical Center Snapshot
Vanderbilt Medical Center Overview
Key Information
Key Facts
Vanderbilt Medical Center – Research and Development Overview
Key Therapeutic Areas
Vanderbilt Medical Center – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Vanderbilt Medical Center – Pipeline Products Glance
Vanderbilt Medical Center – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Vanderbilt Medical Center Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Vanderbilt Medical Center – Drug Profiles
Carbidopa
Product Description
Mechanism of Action
R&D Progress
Hoe 140
Product Description
Mechanism of Action
R&D Progress
ABT-751
Product Description
Mechanism of Action
R&D Progress
Bortezomib + Temozolomide_
Product Description
Mechanism of Action
R&D Progress
Botox
Product Description
Mechanism of Action
R&D Progress
Botulinum Toxin Type A
Product Description
Mechanism of Action
R&D Progress
Cetuximab + RO4929097
Product Description
Mechanism of Action
R&D Progress
Erlotinib + Cetuximab
Product Description
Mechanism of Action
R&D Progress
Phenoxybenzamine
Product Description
Mechanism of Action
R&D Progress
RAD001 + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Tocopherols + Alpha Lipoic Acid
Product Description
Mechanism of Action
R&D Progress
Velcade + Taxotere
Product Description
Mechanism of Action
R&D Progress
Bevacizumab
Product Description
Mechanism of Action
R&D Progress
Cetuximab
Product Description
Mechanism of Action
R&D Progress
Cetuximab + Dasatinib
Product Description
Mechanism of Action
R&D Progress
Dasatinib
Product Description
Mechanism of Action
R&D Progress
Erlotinib + Gemox
Product Description
Mechanism of Action
R&D Progress
Fenofibrate
Product Description
Mechanism of Action
R&D Progress
Imatinib Mesylate + SU011248
Product Description
Mechanism of Action
R&D Progress
Intravenous Citrulline
Product Description
Mechanism of Action
R&D Progress
Melatonin
Product Description
Mechanism of Action
R&D Progress
Metformin Hydrochloride
Product Description
Mechanism of Action
R&D Progress
SJG-136
Product Description
Mechanism of Action
R&D Progress
Vanderbilt Medical Center – Pipeline Analysis
Vanderbilt Medical Center – Pipeline Products by Therapeutic Class
Vanderbilt Medical Center Pipeline Products By Target
Vanderbilt Medical Center – Pipeline Products by Route of Administration
Vanderbilt Medical Center – Pipeline Products by Molecule Type
Vanderbilt Medical Center – Locations And Subsidiaries
Head Office
Financial Deals Landscape
Vanderbilt Medical Center, Deals Summary, 2004 to 2010
Vanderbilt Medical Center Detailed Deal Summary
Acquisition
Vanderbilt Medical Center Acquires The Cardiac Center
Seaside Therapeutics Enters Into Research Collaboration With Vanderbilt University
Walgreens-OptionCare Forms Joint Venture With Vanderbilt Medical Center
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/1582661

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2

Printed Tuesday, May 21, 2013
6:06:00 AM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Vanderbilt Medical Center - Developmental Therapeutics Review - Q4 2010

Web Address

http://www.researchandmarkets.com/reports/1464110

Office Code

OC8DIQSQPUNQVR

Report Formats

Please enter the quantity of the report format you require.

Format	Quantity	Price
Electronic (PDF) - Single User		EURO€ 384.00
Electronic (PDF) - Site License		EURO€ 769.00
Electronic (PDF) - Enterprisewide		EURO€ 1,153.00

Contact information

Please enter all the information below in block capitals.

                Title:
            
                    Mr
                    
                    Mrs
                    
                    Dr
                    
                    Miss
                    
                    Ms
                    
                    Prof
                    
                First Name:
            
                Last Name:
                
                Email Address:
            
                Job Title:
            
                Organisation:
            
                Address:
            
                City:
            
                Postal / Zip Code:	
            
                Country:	
            
                Phone Number:	
            
                Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2

Printed Tuesday, May 21, 2013
6:06:00 AM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:

Cardholder's Signature:

Expiry Date:

Card Number:

CVV Security Code:

Issue date:

(Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:

Account Number:

83313083

Sort Code:

98-53-30

Swift Code:

ULSBIE2D

IBAN Number:

IE78ULSB98533083313083

Bank Address:

Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Printer Friendly

Vanderbilt Medical Center - Developmental Therapeutics Review - Q4 2010

Fax order form

Order information

Product name

Web Address

Office Code

Report Formats

Contact information

Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Payment information

Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)